Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Fludeoxyglucose F-18 (Primary) ; Flutemetamol-F-18 (Primary)
- Indications Breast cancer
- Focus Diagnostic use
- 16 Dec 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 11 Dec 2015 Planned initiation date changed from 1 Oct 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.
- 10 Jun 2015 Planned initiation date changed from 1 Jan 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.